Why Deny Life Saving Drugs to Children?
http://www.cnn.com/2014/03/10/health/cohen-josh/index.html?hpt=hp_c2
This is one of those really sad cases that on the surface, the evil company is holding drugs from dying kids to use, but on a deeper level, it is an issue with how our economic, social, and regulatory model is structured in a way that makes it a no-win scenario.
If this is a problem, I would also say Americans are not alone in the world:
Here's a recent article from the telegraph:
British and European nations hold just as much blood in these issues as Americans. There is no moral superiority, when it comes to medical application.
I love bioethics as a concept with medicine and health care; I've gone to a few assemblies of doctors, hospital management, and health care finance groups with this as the central theme. Patients and their families think if you have treatment that can save lives, why not give it out? There's a lot of good reasons why:
1. Regulations: the FDA is a complicated web of researchers and bureaucrats in drug approval, who have certain rules and limits on anything that even smells like it could harm human beings during testing. On a cursory level, I agree with this concept of being better safe than sorry later, but it is also this kind of mindset that limits scientific advance.
Louis Pasteur in his testing of the Rabies' vaccine, the first human made vaccine in history, was done without extensive prior testing and worse had unmentioned failures in the past that Louis Pasteur had hidden from the medical community. His journals have shown that prior to his successful vaccination of Joseph Meister, he had failed several times prior and had not fine tuned the process.
If modern regulatory standards were held, if these facts were known the field of microbiology, pharmacology, and immunology would not have been created.
Everyone in health care loves to debate Pasteur, because as unethical as he was, his goals were right and his techniques were onto something much larger, the creation of new medical science.
2. Financially: Drug companies are not non-profits and do not create cures for free. They have investors from the usual wall street billionaire to the average office worker with a 401k plan. Our society is founded on the "profit motive", we live by the rule that by investing our resources, then the majority of us can reap the rewards later either from the product or from its sales.
If drugs are given away for free or its value comes into question (drug valuation is another area), then how can investors get their investment back. While drugs may seem cheap from the standpoint of base chemicals and mass production once it hits the hospitals, the true cost is research and time in its development. The investment is a cost of time and resources diverted. If people no longer think it is "worth" investing in such areas, then investment disappears from a pharma company, which in turns means fewer life-saving treatments can be produced.
Capitalism is a sticky point in this area, the alternative is either we pay higher taxes and have the government direct pharmaceutical research "directly" (which is based on public desire versus need, i.e you can find a cure for AIDS or Cancer with all the money thrown into those two big topic diseases, but what about resurgent smallpox, avian flu, or other retroviruses that researchers are working on now with private investment).
There's also another possibility from the individualist, we stop investing altogether since it does not benefit us individually (the Ayn Rand Atlas Shrugged dream, or for me the nightmare of civilization). By the way, there's a hidden danger in Objectivist Libertarianism from this, if taken to the extreme end of individualism, there would be no incentive to pooling resources for non-relevant drugs to individuals, it would reduce overall investment potential and drug production even without government regulations.
3. The Good of the Many versus the Few: CNN does not tell you why this is good for the many versus the few. It only repeats one line from the pharma executives, but the truth is there is a majority good versus minority salvation.
American Society, despite how much is claimed and championed of minority positions, is a society that supports what benefits most people. In this case, you have only one group of interest in the drugs immediate use: Dying children versus the needs of investors, the needs of researchers, and the need for regulatory approval in order to release the drug for wide use. While you may be able to save a few hundred now, you could be saving a few hundred thousand in a year from now.
In medicine, there's a concept that this decision correlates to: Triage.
Resources are not infinite, you can't save everyone, but you must do what you can for the majority. Sometimes people think "Many vs. Few" arguments are relegated to socialist vs free market health care debate in the US, but in fact, it is a reality of civilization itself. Even in a single payer system, you can't avoid it.
Is this a problem with how society is structured that we would throw dying kids under the bus for progress? or Is it merely how we as human beings have adapted to our way of life, in a way showcasing darwinian principles in how our societies are constructed?
Those are bigger questions that people have to answer on their own.
Update:
http://www.cnn.com/2014/03/11/health/josh-hardy-drug-study/index.html?hpt=hp_c2
A deal was struck between the FDA and the Pharma company; 7 year old Josh will get his medicine
However, this was done not by compassion, but a business deal between the government and private sector. It further adds to the question of ethical practice and morality:
Is medicine moving beyond the old Compassionate care model to something based on motives and profits?
14 Comments
Recommended Comments
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now